Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum Days for Lung Cancer Advance Panel Test

Maximum Days for Lung Cancer Advance Panel Test

The report for the Lung Cancer Advance Panel test by NGS can be obtained within 10-14 business days from the date of sample collection.

What are the prerequisites for the test Lung Cancer Advance Panel by NGS

  • Patient must have a confirmed diagnosis of lung cancer
  • Physician's request for the Lung Cancer Advance Panel by NGS
  • Signed informed consent form from the patient
  • Sufficient tissue sample available for testing

What are the measure values for the test Lung Cancer Advance Panel by NGS

  • EGFR (exon 18, 19, 20, 21)
  • KRAS (exon 2, 3, 4)
  • ALK
  • ROS1
  • BRAF (V600E)
  • NTRK1
  • RET

What does this test Lung Cancer Advance Panel by NGS identify?

  • EGFR mutations
  • ALK and ROS1 rearrangements
  • BRAF, MET, RET, and HER2 alterations
  • PDL1 expression levels
  • Other relevant genetic changes associated with lung cancer

Why is this test Lung Cancer Advance Panel by NGS taken?

  • Lung Cancer Advance Panel by NGS is taken to help diagnose and monitor lung cancer.
  • NGS (Next-Generation Sequencing) technology allows for the analysis of multiple genes associated with lung cancer at once, providing a comprehensive view of the genetic changes present in the tumor.
  • This test can help determine the best treatment options for the patient based on the specific genetic mutations detected.
  • It can also be used to track the progression of the disease and monitor response to treatment.

Popular FAQs on Test

The Lung Cancer Advance Panel by NGS is a comprehensive genetic test that uses Next Generation Sequencing technology to analyze multiple genes associated with lung cancer. This test helps in identifying genetic mutations that may be driving the growth of cancer cells in the lung.
The Lung Cancer Advance Panel by NGS test is recommended for patients with lung cancer or suspected lung cancer. It can help in determining the most effective treatment options based on the specific genetic mutations present in the tumor.
The Lung Cancer Advance Panel by NGS test is performed using a small tissue sample from the tumor. The sample is analyzed using Next Generation Sequencing technology to identify genetic mutations in multiple genes associated with lung cancer.
The Lung Cancer Advance Panel by NGS test can help in personalized treatment planning for patients with lung cancer. It can identify specific genetic mutations that may respond to targeted therapies, leading to better outcomes and reduced side effects.
The results of the Lung Cancer Advance Panel by NGS test are typically available within 2-3 weeks after the tissue sample is received by the laboratory.

Customer Google Rating